Dry Needling vs Injection in Patients With Temporomandibular Disorders

Launched by JOSUE FERNANDEZ CARNERO · Jan 25, 2021

Keywords

ClinConnect Summary

This clinical trial is studying two treatment options for people with Temporomandibular Disorders (TMD), a condition that can cause pain in the jaw and face. The researchers want to see how effective dry needling (a technique where thin needles are inserted into muscles) is compared to a placebo (a treatment with no active ingredients) and an injection in relieving pain and improving daily activities for those with TMD that comes from muscle issues. They will look at the results over different time periods: short-term, medium-term, and long-term.

To participate in the trial, individuals need to be between 18 and 60 years old and have had pain in the jaw or face for more than six weeks. It’s important that the pain is related to the muscles used for chewing. However, people who have had any injections or dry needling in the last three months, have certain types of TMD, recent injuries or infections in the jaw area, blood clotting issues, or are pregnant won't be eligible to join. Participants can expect to be part of a study that aims to find better ways to manage their TMD symptoms, contributing to important research that could help many others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Subjects aged between 18 and 60 years.
• • 2. Pain of more than 6 weeks of evolution in the craniofacial region.
• • 3. TMD with origin in the masticatory musculature according to the "DC-TMD" criteria.
• Exclusion Criteria:
• • 1. Previous injection or dry needling intervention (3 months) on the masseter muscle.
• • 2. Arthrogenous TMD.
• • 3. History of trauma, infection in the temporomandibular joint in the last 6 months.
• • 4. Coagulation disorders.
• • 5. Pregnancy.